{"name": "ProNAi Therapeutics", "permalink": "pronai-therapeutics", "crunchbase_url": "http://www.crunchbase.com/company/pronai-therapeutics", "homepage_url": "http://www.pronai.com/", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": null, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "info@pronai.com", "phone_number": "(269) 815-8098 ", "description": "", "created_at": "Thu Mar 15 03:56:05 UTC 2012", "updated_at": "Thu Mar 15 03:56:04 UTC 2012", "overview": "\u003Cp\u003EProNAi Therapeutics, Inc. is a DNA Interference (DNAi\u00ae)-based biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi\u00ae, to advance a next generation of therapies for patients with cancer and other complex genetic diseases.\u003C/p\u003E", "image":  {"available_sizes":    [[[150,       45],      "assets/images/resized/0017/8345/178345v1-max-150x150.png"],     [[240,       73],      "assets/images/resized/0017/8345/178345v1-max-250x250.png"],     [[240,       73],      "assets/images/resized/0017/8345/178345v1-max-450x450.png"]],   "attribution": null}, "products":  [], "relationships":  [{"is_past": false,    "title": "President and CEO",    "person":     {"first_name": "Charles",      "last_name": "Bisgaier",      "permalink": "charles-bisgaier"}}], "competitions":  [], "providerships":  [], "total_money_raised": "$0", "funding_rounds":  [], "investments":  [], "acquisition": null, "acquisitions":  [], "offices":  [{"description": "",    "address1": "2725 South Industrial Hwy",    "address2": "Suite 200",    "zip_code": "48104",    "city": "Ann Arbor",    "state_code": "MI",    "country_code": "USA",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [], "external_links":  []}